Carmichael Hill & Associates’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.36K Hold
14
﹤0.01% 722
2024
Q2
$1.2K Hold
14
﹤0.01% 722
2024
Q1
$1.16K Hold
14
﹤0.01% 714
2023
Q4
$935 Hold
14
﹤0.01% 741
2023
Q3
$941 Hold
14
﹤0.01% 734
2023
Q2
$948 Hold
14
﹤0.01% 739
2023
Q1
$758 Hold
14
﹤0.01% 737
2022
Q4
$837 Hold
14
﹤0.01% 732
2022
Q3
$1K Sell
14
-4
-22% -$200 ﹤0.01% 767
2022
Q2
$1K Buy
+18
New +$923 ﹤0.01% 759

Other funds holding EHC

Carmichael Hill & Associates's EHC Position: Q3 2024 in Review

Carmichael Hill & Associates held its Encompass Health (EHC) position steady in Q3 2024 at 14 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #722.

Carmichael Hill & Associates first reported a position in EHC in Q2 2022 and has held it in 10 quarters since. 483 funds tracked by Wall St. Rank hold EHC as of Q3 2024.

  • Carmichael Hill & Associates held 14 shares of Encompass Health worth $1.36K as of Q3 2024.
  • Carmichael Hill & Associates left its Encompass Health share count unchanged in Q3 2024.
  • Encompass Health made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #722 holding.
  • Carmichael Hill & Associates first reported a position in Encompass Health in Q2 2022 and has held it in 10 quarters since.
  • 483 funds tracked by Wall St. Rank held Encompass Health as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.